Acadia Pharmaceuticals | Umlaufvermögen

Aktienkurs
24.56
Täglich Wechseln
-0.08 -0.32%
Monatlich
-4.14%
Jährlich
25.31%
Q1 Prognose
23.80




Umlaufvermögen Veränderung Datum
Acadia Pharmaceuticals USD 1.06B 14.31M 2025-12
ALKERMES USD 1.93B 187.5M 2025-12
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
Biogen USD 8.97B 37.5M 2025-12
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Cara Therapeutics USD 43.13M 4.18M 2025-06
Corcept Therapeutics USD 485.46M 55.67M 2025-12
Cytokinetics USD 916.97M 60.37M 2025-12
Eisai JPY 840.88B 50.18B 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Incyte USD 5.02B 746.01M 2025-12
J&J USD 55.62B 1.01B 2025-12
Moderna USD 6.54B 54M 2025-12
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Prothena USD 339.97M 45.51M 2025-09
PTC Therapeutics USD 2.27B 266.14M 2025-12
Sarepta Therapeutics USD 2.54B 184.37M 2025-12
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12


Acadia Pharmaceuticals Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.